Orforglipron|Wegovy|Retatrutide

The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like Zepbound (tirzepatide) and Wegovy (semaglutide).

But as we move through 2026, the “second generation” of obesity treatments has arrived, offering more convenience and, in some cases, power that rivals bariatric surgery.

If you are navigating the options for medical weight loss, here is everything you need to know about the three most talked-about medications today.

1. The Convenience King: Orforglipron (Foundayo)

Until recently, oral GLP-1 medications were notoriously finicky. Orforglipron changed that. Unlike previous versions, it is a “small molecule” drug, meaning it isn’t easily destroyed by stomach acid.

• How it’s taken: A simple daily pill.
• The Big Advantage: Flexibility. You can take it with or without food, any time of day.
• Expected Results: Trials show an average weight loss of 11% to 15%.
• Best For: The busy professional or traveler who wants results without the “fasting rituals” required by other oral medications.

2. The Proven Performer: Oral Semaglutide (Wegovy)

Semaglutide is the gold standard of the GLP-1 world. While it started as an injection, the high-dose Wegovy Pill (25 mg and 50 mg) has now moved from clinical trials to pharmacy shelves.

• How it’s taken: A daily pill taken on a strict empty stomach.
• The Big Advantage: It uses the most studied molecule in the industry. We have years of safety data on semaglutide, and the high-dose pill delivers weight loss that nearly matches the weekly injections.
• Expected Results: Impressive weight loss ranging from 13% to 17%.
• Best For: Those who want a medication with a long, proven track record and are disciplined enough to follow a strict morning fasting routine.

3. The “Triple Threat”: Retatrutide

If orforglipron and Wegovy are high-performance sedans, Retatrutide is a rocket ship. It is currently the only “triple agonist” in advanced development, targeting three different hormones: GLP-1, GIP, and Glucagon.

• How it’s taken: A weekly injection.
• The Big Advantage: Unprecedented power. By adding Glucagon to the mix, Retatrutide doesn’t just suppress appetite; it actually signals the body to burn more energy. It also shows significant promise in clearing fat from the liver.
• Expected Results: In Phase 2 and 3 trials, participants lost a staggering 24% to 30% of their body weight.
• Best For: Individuals with significant obesity or metabolic stalling who require “surgery-level” weight loss and don’t mind a weekly needle.

Comparison at a Glance

Which one is right for you?

The “best” medication isn’t always the one that sheds the most pounds; it’s the one that fits your lifestyle and your body’s specific chemistry.

• Prioritize Ease of Use? Go with Orforglipron.
• Prioritize a Proven Track Record? The Wegovy Pill is your best bet.
• Prioritize Maximum Results? Retatrutide may be the future heavyweight champion.
• Safety Note: All three medications can cause gastrointestinal side effects like nausea or changes in heart rate. As with any significant medical intervention, a consultation with a specialist is essential to review your history, especially regarding thyroid or pancreatic health, before beginning treatment.